Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination

Immunology Letters

Volumn 148, Issue 1, 2012, Pages 77-82

  Jamali, Abbas ^a,b   Holtrop, Marijke ^b   de Haan, Aalzen ^b   Hashemi, Hamidreza ^c   Shenagari, Mohammad ^d,e   Memarnejadian, Arash ^a   Roohvand, Farzin ^a   Sabahi, Farzaneh ^e   Kheiri, Masumeh Tavassoti ^a   Huckriede, Anke ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Adjuvant; Cationic influenza virosomes; CTL responses; DNA vaccines

Indexed keywords

DNA VACCINE; EPITOPE; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIROSOME VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; ENZYME RELEASE; FEMALE; GENETIC TRANSFECTION; IMMUNIZATION; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CATIONS; CELL LINE; DNA, VIRAL; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; GRANZYMES; INJECTIONS, INTRADERMAL; INTERFERON-GAMMA; LIPIDS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIROSOMES;

EID: 84866517622     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.08.006     Document Type: Article

References (39)

1. Genesca M. Characterization of an effective CTL response against HIV and SIV infections. J Biomed Biotechnol 2011, Article ID 103924.
2. Torresi J., Bharadwaj M., Jackson D.C., Gowans E.J. Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy. Curr Drug Targets 2004, 5:41-56.
3. Brown L.E., Kelso A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol 2009, 87:300-308.
4. Pouriayevali M.H., Bamdad T., Parsania M., Sari R.D. Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy. Cell Immunol 2011, 268:4-8.
5. Martin P., Simon B., Lone Y.C., Chatel L., Barry R., Inchauspe G., et al. A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus. Vaccine 2008, 26:2471-2481.
6. Fuller D.H., Rajakumar P., Che J.W., Narendran A., Nyaundi J., Michael H., et al. Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques. PLoS One 2012, 7:e33715.
7. Liu M.A. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011, 239:62-84.
8. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003, 21:649-658.
9. Houghton M. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Immunol Rev 2011, 239:99-108.
10. Horner A.A., Datta S.K., Takabayashi K., Belyakov I.M., Hayashi T., Cinman N., et al. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J Immunol 2001, 167:1584-1591.
11. Kojima Y., Xin K.Q., Ooki T., Hamajima K., Oikawa T., Shinoda K., et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 2002, 20:2857-2865.
12. Pardoll D.M., Beckerleg A.M. Exposing the immunology of naked DNA vaccines. Immunity 1995, 3:165-169.
13. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 2008, 60:915-928.
14. Kumar V.V., Singh R.S., Chaudhuri A. Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr Med Chem 2003, 10:1297-1306.
15. Dass C.R. Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J Mol Med (Berl) 2004, 82:579-591.
16. Miller A.D. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr Med Chem 2003, 10:1195-1211.
17. Stegmann T., Morselt H.W., Booy F.P., van Breemen J.F., Scherphof G., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J 1987, 6:2651-2659.
18. Cusi M.G. Applications of influenza virosomes as a delivery system. Hum Vaccin 2006, 2:1-7.
19. de Jonge J., Leenhouts J.M., Holtrop M., Schoen P., Scherrer P., Cullis P.R., et al. Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. Biochem J 2007, 405:41-49.
20. Daemen T., de Mare A., Bungener L., de Jonge J., Huckriede A., Wilschut J. Virosomes for antigen and DNA delivery. Adv Drug Deliv Rev 2005, 57:451-463.
21. Cusi M.G., Zurbriggen R., Valassina M., Bianchi S., Durrer P., Valensin P.E., et al. Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity. Virology 2000, 277:111-118.
22. Correale P., Cusi M.G., Sabatino M., Micheli L., Pozzessere D., Nencini C., et al. Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes. Eur J Cancer 2001, 37:2097-2103.
23. Memarnejadian A., Roohvand F. Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine. Cell Immunol 2010, 261:93-98.
24. Schoen P., Chonn A., Cullis P.R., Wilschut J., Scherrer P. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther 1999, 6:823-832.
25. Cusi M.G., Terrosi C., Savellini G.G., Di Genova G., Zurbriggen R., Correale P. Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 2004, 22:735-739.
26. Donnelly J.J., Wahren B., Liu M.A. DNA vaccines: progress and challenges. J Immunol 2005, 175:633-639.
27. Dokka S., Toledo D., Shi X., Ye J., Rojanasakul Y. High-efficiency gene transfection of macrophages by lipoplexes. Int J Pharm 2000, 206:97-104.
28. Matlin K.S., Reggio H., Helenius A., Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 1981, 91:601-613.
29. Hofer U., Lehmann A.D., Waelti E., Amacker M., Gehr P., Rothen-Rutishauser B. Virosomes can enter cells by non-phagocytic mechanisms. J Liposome Res 2009, 19:301-309.
30. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
31. Chattergoon M.A., Robinson T.M., Boyer J.D., Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 1998, 160:5707-5718.
32. Gluck R., Moser C., Metcalfe I.C. Influenza virosomes as an efficient system for adjuvanted vaccine delivery. Expert Opin Biol Ther 2004, 4:1139-1145.
33. Moser C., Metcalfe I.C., Viret J.F. Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2003, 2:189-196.
34. Yan W., Chen W., Huang L. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Mol Immunol 2007, 44:3672-3681.
35. Babiuk L.A., van Drunen Littel-van den H., Babiuk S.L. Immunization of animals: from DNA to the dinner plate. Vet Immunol Immunopathol 1999, 72:189-202.
36. Sardesai N.Y., Weiner D.B. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011, 23:421-429.
37. Sullivan S.M., Doukas J., Hartikka J., Smith L., Rolland A. Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines. Expert Opin Drug Deliv 2010, 7:1433-1446.
38. de Mare A., Bungener L.B., Regts J., de Vries-Idema J., van der Zee A.G., Wilschut J., et al. The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity. Vaccine 2008, 26:2314-2321.
39. Bins A.D., Jorritsma A., Wolkers M.C., Hung C.F., Wu T.C., Schumacher T.N., et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005, 11:899-904.